Your browser doesn't support javascript.
loading
Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.
Beije, N; de Kruijff, I E; de Jong, J J; Klaver, S O; de Vries, P; Jacobs, R A L; Somford, D M; Te Slaa, E; van der Heijden, A G; Alfred Witjes, J; Fossion, L M C L; Boevé, E R; van der Hoeven, J; van Melick, H H E; Wijburg, C J; Bickerstaffe, H; Martens, J W M; de Wit, R; Kraan, J; Sleijfer, S; Boormans, J L.
Afiliação
  • Beije N; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: n.beije@erasmusmc.nl.
  • de Kruijff IE; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • de Jong JJ; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Klaver SO; Department of Urology, Maasstad Hospital, Rotterdam, The Netherlands.
  • de Vries P; Department of Urology, Zuyderland Medical Center, Heerlen, The Netherlands.
  • Jacobs RAL; Department of Urology, Zuyderland Medical Center, Heerlen, The Netherlands.
  • Somford DM; Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
  • Te Slaa E; Department of Urology, Isala Hospital, Zwolle, The Netherlands.
  • van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Alfred Witjes J; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Fossion LMCL; Department of Urology, Maxima MC, Eindhoven, The Netherlands.
  • Boevé ER; Department of Urology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
  • van der Hoeven J; Department of Urology, Reinier de Graaf Gasthuis, Delft, The Netherlands.
  • van Melick HHE; Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Wijburg CJ; Department of Urology, Rijnstate Hospital, Arnhem, The Netherlands.
  • Bickerstaffe H; Department of Urology, Bravis Hospital, Roosendaal, The Netherlands.
  • Martens JWM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • de Wit R; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Kraan J; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Sleijfer S; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Boormans JL; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
ESMO Open ; 7(2): 100416, 2022 04.
Article em En | MEDLINE | ID: mdl-35248823
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Células Neoplásicas Circulantes Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: ESMO Open Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Células Neoplásicas Circulantes Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: ESMO Open Ano de publicação: 2022 Tipo de documento: Article